Literature DB >> 8056940

Assessing patient dependence in Alzheimer's disease.

Y Stern1, S M Albert, M Sano, M Richards, L Miller, M Folstein, M Albert, F W Bylsma, G Lafleche.   

Abstract

BACKGROUND: While cognitive and functional deficits are the hallmark of Alzheimer's disease (AD), loss of social function (and the dependence this implies) is also critical, especially in early stages of disease. Little attention has been directed to this facet of dementing disease. We describe a scale for assessing dependency in AD and present a baseline profile of dependency in a cohort of AD patients.
METHODS: In a study of the predictors of the course of AD, 233 patients in early stages of disease (modified MMS > or = 30) were assessed. Psychometric properties of the dependence scale were established. To validate the scale, dependence scores at baseline were correlated with a series of measures assessing cognition and function. The course of dependency over 18 months of follow-up was also analyzed.
RESULTS: The scale shows adequate reliability (test-retest, intraclass correlation). Dependence stage was related to other measures of disease severity. Scalogram analysis shows that the dependence scale is consistent with the course of functional loss established for dementing disease. Prospective data indicate sensitivity of the scale to disease progression.
CONCLUSION: Dependency is a distinct, measurable component of dementing disease and should be considered an important outcome in studies of AD.

Entities:  

Mesh:

Year:  1994        PMID: 8056940     DOI: 10.1093/geronj/49.5.m216

Source DB:  PubMed          Journal:  J Gerontol        ISSN: 0022-1422


  59 in total

1.  Effectiveness of rivastigmine in Alzheimer's disease. Participation in trials should be based on clinical uncertainty, not enforcement.

Authors:  R Bullock; P Passmore; D Wilkinson; R Howard; R Jones
Journal:  BMJ       Date:  2000-02-19

2.  Clinical and Economic Characteristics of Milestones along the Continuum of Alzheimer's Disease: Transforming Functional Scores into Levels of Dependence.

Authors:  K Kahle-Wrobleski; J S Andrews; M Belger; S Gauthier; Y Stern; D M Rentz; D Galasko
Journal:  J Prev Alzheimers Dis       Date:  2015-01-20

3.  Effect of second-generation antipsychotics on caregiver burden in Alzheimer's disease.

Authors:  Somaia Mohamed; Robert Rosenheck; Constantine G Lyketsos; Richard Kaczynski; David L Sultzer; Lon S Schneider
Journal:  J Clin Psychiatry       Date:  2011-09-06       Impact factor: 4.384

4.  Estimation and validation of a multiattribute model of Alzheimer disease progression.

Authors:  Eric Stallard; Bruce Kinosian; Arthur S Zbrozek; Anatoliy I Yashin; Henry A Glick; Yaakov Stern
Journal:  Med Decis Making       Date:  2010 Nov-Dec       Impact factor: 2.583

Review 5.  A systematic review to assess the policy-making relevance of dementia cost-of-illness studies in the US and Canada.

Authors:  Mark Oremus; S Carolina Aguilar
Journal:  Pharmacoeconomics       Date:  2011-02       Impact factor: 4.981

6.  Bridging from clinical endpoints to estimates of treatment value for external decision makers.

Authors:  C W Zhu; C Leibman; R Townsend; T McLaughlin; N Scarmeas; M Albert; J Brandt; D Blacker; M Sano; Y Stern
Journal:  J Nutr Health Aging       Date:  2009-03       Impact factor: 4.075

7.  Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial.

Authors:  Maurice W Dysken; Mary Sano; Sanjay Asthana; Julia E Vertrees; Muralidhar Pallaki; Maria Llorente; Susan Love; Gerard D Schellenberg; J Riley McCarten; Julie Malphurs; Susana Prieto; Peijun Chen; David J Loreck; George Trapp; Rajbir S Bakshi; Jacobo E Mintzer; Judith L Heidebrink; Ana Vidal-Cardona; Lillian M Arroyo; Angel R Cruz; Sally Zachariah; Neil W Kowall; Mohit P Chopra; Suzanne Craft; Stephen Thielke; Carolyn L Turvey; Catherine Woodman; Kimberly A Monnell; Kimberly Gordon; Julie Tomaska; Yoav Segal; Peter N Peduzzi; Peter D Guarino
Journal:  JAMA       Date:  2014-01-01       Impact factor: 56.272

8.  Social cognition in Alzheimer's disease: a separate construct contributing to dependence.

Authors:  Stephanie Cosentino; Laura B Zahodne; Jason Brandt; Deborah Blacker; Marilyn Albert; Bruno Dubois; Yaakov Stern
Journal:  Alzheimers Dement       Date:  2014-03-18       Impact factor: 21.566

9.  Vitamin E and memantine in Alzheimer's disease: clinical trial methods and baseline data.

Authors:  Maurice W Dysken; Peter D Guarino; Julia E Vertrees; Sanjay Asthana; Mary Sano; Maria Llorente; Muralidhar Pallaki; Susan Love; Gerard D Schellenberg; J Riley McCarten; Julie Malphurs; Susana Prieto; Peijun Chen; David J Loreck; Sara Carney; George Trapp; Rajbir S Bakshi; Jacobo E Mintzer; Judith L Heidebrink; Ana Vidal-Cardona; Lillian M Arroyo; Angel R Cruz; Neil W Kowall; Mohit P Chopra; Suzanne Craft; Stephen Thielke; Carolyn L Turvey; Catherine Woodman; Kimberly A Monnell; Kimberly Gordon; Julie Tomaska; Govind Vatassery
Journal:  Alzheimers Dement       Date:  2013-04-11       Impact factor: 21.566

10.  The effects of patient function and dependence on costs of care in Alzheimer's disease.

Authors:  Carolyn W Zhu; Christopher Leibman; Trent McLaughlin; Nikolaos Scarmeas; Marilyn Albert; Jason Brandt; Deborah Blacker; Mary Sano; Yaakov Stern
Journal:  J Am Geriatr Soc       Date:  2008-07-24       Impact factor: 5.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.